Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.19.6 extracted from

  • Bauer, K.; Nowak, P.; Kleinkauf, H.
    Specificity of a serum peptidase hydrolyzing thyroliberin at pyroglutamyl-histidine bone (1981), Eur. J. Biochem., 118, 173-176.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
Luliberin
-
Sus scrofa
neurotensin
-
Sus scrofa
Thyroliberin analogues LLD-thyroliberin, pyroglutamyl-His-Pro-NHCH3, pyroglutamyl-His-Pro-Gly-NHCH3, pyroglutamyl-Phe-Pro-NH2 Sus scrofa

KM Value [mM]

KM Value [mM] KM Value Maximum [mM] Substrate Comment Organism Structure
0.056
-
Thyroliberin
-
Sus scrofa

Organism

Organism UniProt Comment Textmining
Sus scrofa
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
serum
-
Sus scrofa
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
additional information no hydrolysis of pyroglutamyl-His Sus scrofa ?
-
?
additional information no hydrolysis of pyroglutamyl-Ala or pyroglutamyl 2-naphthylamide (known substrates of the serum enzyme) Sus scrofa ?
-
?
additional information no hydrolysis of neurotensin Sus scrofa ?
-
?
additional information no hydrolysis of thyroliberin analogues LLD-thyroliberin, pyroglutamyl-His-Pro-NHCH3, pyroglutamyl-His-Pro-Gly-NHCH3 or pyroglutamyl-Phe-Pro-NH2 Sus scrofa ?
-
?
additional information no hydrolysis of luliberin Sus scrofa ?
-
?
thyroliberin + H2O rapid stereospecific cleavage only of the pyroglutamyl-histidine bond of thyroliberin and closely related peptides Sus scrofa pyroglutamic acid + His-Pro-NH2
-
?